Omega-3 EPA linked to longer survival after surgery for colorectal cancer liver metastases

Patients assigned to receive high-dose eicosapentaenoic acid an omega-3 fatty acid, before and after surgery for colorectal cancer liver metastases had longer overall survival than those assigned to receive placebo, according to results of the phase 3 EMT2 trial presented at the ESMO Congress 2026, held in Madrid Oct. 23–27.

Read it at Medical Xpress ↗

← Front page